Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response
The incretin effect is impaired in type 2 diabetes (T2D), but the underlying mechanisms are only partially understood. We investigated the relationships between the time course of the incretin effect and that of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) during oral glucose tolerance tests (OGTTs), thereby estimating incretin sensitivity of the beta cell, and its associated factors.
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - Category: Nutrition Authors: A. Tura, J.I. Bagger, E. Ferrannini, J.J. Holst, F.K. Knop, T. Vilsb øll, A. Mari Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Incretin Therapy | Nutrition